vs
Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $111.5M, roughly 1.5× AVIAT NETWORKS, INC.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -5.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 0.3%).
Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
AVNW vs ESPR — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $111.5M | $168.4M |
| Net Profit | $5.7M | — |
| Gross Margin | 32.4% | — |
| Operating Margin | 6.5% | 50.6% |
| Net Margin | 5.1% | — |
| Revenue YoY | -5.7% | 143.7% |
| Net Profit YoY | 27.2% | — |
| EPS (diluted) | $0.44 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $111.5M | $168.4M | ||
| Q3 25 | $107.3M | $87.3M | ||
| Q2 25 | $115.3M | $82.4M | ||
| Q1 25 | $112.6M | $65.0M | ||
| Q4 24 | $118.2M | $69.1M | ||
| Q3 24 | $88.4M | $51.6M | ||
| Q2 24 | $116.7M | $73.8M | ||
| Q1 24 | $110.8M | $137.7M |
| Q4 25 | $5.7M | — | ||
| Q3 25 | $162.0K | $-31.3M | ||
| Q2 25 | $5.2M | $-12.7M | ||
| Q1 25 | $3.5M | $-40.5M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $-11.9M | $-29.5M | ||
| Q2 24 | $1.5M | $-61.9M | ||
| Q1 24 | $3.9M | $61.0M |
| Q4 25 | 32.4% | — | ||
| Q3 25 | 33.2% | — | ||
| Q2 25 | 34.2% | — | ||
| Q1 25 | 34.9% | — | ||
| Q4 24 | 34.6% | — | ||
| Q3 24 | 22.4% | — | ||
| Q2 24 | 35.3% | — | ||
| Q1 24 | 32.5% | — |
| Q4 25 | 6.5% | 50.6% | ||
| Q3 25 | 4.8% | -11.4% | ||
| Q2 25 | 7.7% | 8.6% | ||
| Q1 25 | 8.3% | -34.0% | ||
| Q4 24 | 6.7% | -6.4% | ||
| Q3 24 | -17.6% | -31.0% | ||
| Q2 24 | 4.7% | 3.5% | ||
| Q1 24 | 5.1% | 52.5% |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 0.2% | -35.9% | ||
| Q2 25 | 4.5% | -15.4% | ||
| Q1 25 | 3.1% | -62.2% | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | -13.4% | -57.2% | ||
| Q2 24 | 1.3% | -83.9% | ||
| Q1 24 | 3.5% | 44.3% |
| Q4 25 | $0.44 | $0.32 | ||
| Q3 25 | $0.01 | $-0.16 | ||
| Q2 25 | $0.42 | $-0.06 | ||
| Q1 25 | $0.27 | $-0.21 | ||
| Q4 24 | $0.35 | $-0.14 | ||
| Q3 24 | $-0.94 | $-0.15 | ||
| Q2 24 | $0.11 | $-0.33 | ||
| Q1 24 | $0.30 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.5M | $167.9M |
| Total DebtLower is stronger | $105.4M | — |
| Stockholders' EquityBook value | $271.6M | $-302.0M |
| Total Assets | $659.4M | $465.9M |
| Debt / EquityLower = less leverage | 0.39× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $86.5M | $167.9M | ||
| Q3 25 | $64.8M | $92.4M | ||
| Q2 25 | $59.7M | $86.1M | ||
| Q1 25 | $49.4M | $114.6M | ||
| Q4 24 | $52.6M | $144.8M | ||
| Q3 24 | $51.0M | $144.7M | ||
| Q2 24 | $64.6M | $189.3M | ||
| Q1 24 | $59.2M | $226.6M |
| Q4 25 | $105.4M | — | ||
| Q3 25 | $106.5M | — | ||
| Q2 25 | $87.6M | — | ||
| Q1 25 | $73.9M | — | ||
| Q4 24 | $74.9M | — | ||
| Q3 24 | $83.4M | — | ||
| Q2 24 | $48.4M | — | ||
| Q1 24 | $48.9M | — |
| Q4 25 | $271.6M | $-302.0M | ||
| Q3 25 | $263.6M | $-451.4M | ||
| Q2 25 | $263.2M | $-433.5M | ||
| Q1 25 | $256.1M | $-426.2M | ||
| Q4 24 | $249.6M | $-388.7M | ||
| Q3 24 | $247.1M | $-370.2M | ||
| Q2 24 | $255.9M | $-344.2M | ||
| Q1 24 | $256.0M | $-294.3M |
| Q4 25 | $659.4M | $465.9M | ||
| Q3 25 | $643.3M | $364.0M | ||
| Q2 25 | $633.3M | $347.1M | ||
| Q1 25 | $628.3M | $324.0M | ||
| Q4 24 | $594.1M | $343.8M | ||
| Q3 24 | $590.9M | $314.1M | ||
| Q2 24 | $535.2M | $352.3M | ||
| Q1 24 | $490.3M | $373.1M |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $45.2M |
| Free Cash FlowOCF − Capex | $22.5M | — |
| FCF MarginFCF / Revenue | 20.2% | — |
| Capex IntensityCapex / Revenue | 1.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $45.2M | ||
| Q3 25 | $-11.7M | $-4.3M | ||
| Q2 25 | $10.5M | $-31.4M | ||
| Q1 25 | $1.6M | $-22.6M | ||
| Q4 24 | $20.8M | $-35.0M | ||
| Q3 24 | $-27.2M | $-35.3M | ||
| Q2 24 | $8.3M | $-7.2M | ||
| Q1 24 | $15.3M | $53.8M |
| Q4 25 | $22.5M | — | ||
| Q3 25 | $-13.5M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $18.3M | — | ||
| Q3 24 | $-32.6M | $-35.5M | ||
| Q2 24 | $7.5M | $-7.3M | ||
| Q1 24 | $14.8M | $53.8M |
| Q4 25 | 20.2% | — | ||
| Q3 25 | -12.6% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | -1.0% | — | ||
| Q4 24 | 15.5% | — | ||
| Q3 24 | -36.8% | -68.7% | ||
| Q2 24 | 6.4% | -9.9% | ||
| Q1 24 | 13.4% | 39.0% |
| Q4 25 | 1.3% | 0.0% | ||
| Q3 25 | 1.6% | 0.0% | ||
| Q2 25 | 2.0% | 0.0% | ||
| Q1 25 | 2.5% | 0.0% | ||
| Q4 24 | 2.1% | 0.0% | ||
| Q3 24 | 6.1% | 0.3% | ||
| Q2 24 | 0.7% | 0.1% | ||
| Q1 24 | 0.4% | 0.1% |
| Q4 25 | 4.18× | — | ||
| Q3 25 | -72.48× | — | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 4.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
